ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,408Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 96

$1.18M Total Retail Price of All Prescriptions

Rank: 5 out of 96

776 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 776 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

2% of this provider’s 776 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 15,667 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 952 911 1 2
DIOVAN 659 613 2 17
SIMVASTATIN 609 561 3 1
METOPROLOL TARTRATE 440 418 4 7
METFORMIN HCL 437 359 5 13
OMEPRAZOLE 419 388 6 5
FUROSEMIDE 368 337 7 4
ENALAPRIL MALEATE 305 275 8 28
HYDROCHLOROTHIAZIDE 304 287 9 16
OXYCODONE-ACETAMINOPHEN 299 252 S2 10 26
ZOLPIDEM TARTRATE 274 246 11 18
CRESTOR 264 256 12 39
CARVEDILOL 233 199 13 22
ATORVASTATIN CALCIUM 231 224 14 12
FAMOTIDINE 228 209 15 21
LEVOTHYROXINE SODIUM 218 208 16 3
WARFARIN SODIUM 211 200 17 6
LISINOPRIL 203 193 18 10
DIOVAN HCT 202 186 19 64
NEXIUM 188 172 20 40
BYSTOLIC 186 153 21 56
GABAPENTIN 185 145 22 20
NAMENDA 170 170 23 11
EXELON 163 163 24 47
AZITHROMYCIN 161 147 25 54
LACTULOSE 154 144 26 37
LEVOFLOXACIN 152 139 27 59
DONEPEZIL HCL 148 148 28 8
NAPROXEN 136 125 29 140
RAMIPRIL 133 121 30 69
METOPROLOL SUCCINATE 132 124 31 9
CLOPIDOGREL 131 114 32 27
ALENDRONATE SODIUM 129 126 33 36
GLIMEPIRIDE 128 112 34 43
LOSARTAN POTASSIUM 125 121 35 23
POTASSIUM CHLORIDE 122 122 36 19
SPIRIVA 121 118 37 67
PLAVIX 119 110 38 42
MELOXICAM 114 114 39 65
ADVAIR DISKUS 114 101 39 46
ATENOLOL 112 106 41 30
TAMSULOSIN HCL 111 100 42 29
VESICARE 110 110 43 121
TRAMADOL HCL-ACETAMINOPHEN 107 100 44 81
PROAIR HFA 100 85 45 72
RISPERIDONE 95 90 46 31
FENTANYL 91 76 S2 47 50
BENICAR 90 90 48 151
HYDRALAZINE HCL 86 86 49 79
JANUVIA 84 84 50 49
ESCITALOPRAM OXALATE 83 83 51 24
TRAMADOL HCL 82 80 52 35
ZETIA 81 76 53 110
DIGOXIN 79 74 54 34
LIPITOR 78 78 55 63
PRAVASTATIN SODIUM 77 67 56 33
ISOSORBIDE MONONITRATE ER 73 68 57 60
SERTRALINE HCL 73 65 57 15
LANTUS 69 61 59 68
AGGRENOX 66 66 60 170
SINGULAIR 65 63 61 78
BACLOFEN 64 45 62 108
CLOTRIMAZOLE-BETAMETHASONE 64 53 62 101
POLYETHYLENE GLYCOL 3350 64 59 62 53
CLONIDINE HCL 64 41 62 74
LIDODERM 63 63 66 45
LEVETIRACETAM 59 27 67 61
LANSOPRAZOLE 58 50 68 193
ENDOCET 58 26 S2 68 94
PANTOPRAZOLE SODIUM 58 57 68 44
OXYCONTIN 57 27 S2 71 118
QUETIAPINE FUMARATE 56 54 72 32
PRADAXA 56 43 72 150
MUPIROCIN 56 41 72 132
MIRTAZAPINE 55 54 75 14
IBUPROFEN 53 48 76 138
SANTYL 53 50 76 71
CITALOPRAM HBR 52 52 78 25
PAROXETINE HCL 52 43 78 66
TRICOR 50 46 80 111
NOVOLIN 70-30 50 39 80 267
GLYBURIDE 50 50 R 80 136
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.